Cyclo Therapeutics Inc
NASDAQ:CYTH

Watchlist Manager
Cyclo Therapeutics Inc Logo
Cyclo Therapeutics Inc
NASDAQ:CYTH
Watchlist
Price: 0.72 USD -2.7% Market Closed
Market Cap: 20.7m USD
Have any thoughts about
Cyclo Therapeutics Inc?
Write Note

Cyclo Therapeutics Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cyclo Therapeutics Inc
Free Cash Flow Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Cyclo Therapeutics Inc
NASDAQ:CYTH
Free Cash Flow
-$18.4m
CAGR 3-Years
-9%
CAGR 5-Years
-34%
CAGR 10-Years
-49%
Abbvie Inc
NYSE:ABBV
Free Cash Flow
$15.6B
CAGR 3-Years
-10%
CAGR 5-Years
4%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Free Cash Flow
$10B
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
0%
Amgen Inc
NASDAQ:AMGN
Free Cash Flow
$6.3B
CAGR 3-Years
-7%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Free Cash Flow
-$1.4B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-13%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Free Cash Flow
$3.3B
CAGR 3-Years
-15%
CAGR 5-Years
11%
CAGR 10-Years
20%

See Also

What is Cyclo Therapeutics Inc's Free Cash Flow?
Free Cash Flow
-18.4m USD

Based on the financial report for Jun 30, 2024, Cyclo Therapeutics Inc's Free Cash Flow amounts to -18.4m USD.

What is Cyclo Therapeutics Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-49%

Over the last year, the Free Cash Flow growth was -33%. The average annual Free Cash Flow growth rates for Cyclo Therapeutics Inc have been -9% over the past three years , -34% over the past five years , and -49% over the past ten years .

Back to Top